We report a case of an 17-year-old male with a drug reaction in the spectrum of Stevens-Johnson syndrome (SJS)/toxic epidermal necrolysis (TEN), triggered by carbamazepine, who was succesfully treated with the combination of dexamethasone, cyclosporine, and etanercept. This triple therapy halted and prevented skin epidermolysis without immediate or late onset complications.
AntoonJWGoldmanJLLeeBSchwartzA. Incidence, outcome, and resource use in children with Stevens-Johnson syndrome and toxic epidermal necrolysis. Pediatr Dermatol. 2018;35(2):182-187. doi:10.1111/pde.13383
2.
ChungEHHungSiYangJYet al. Granulysin is a key mediator for disseminated keratinocyte death in Stevens-Johnson syndrome and toxic epidermal necrolysis. Nat Med. 2008;14(12):1343-1350. doi:10.1038/nm.1884
3.
HengYKLeeHYRoujeauJC. Epidermal necrolysis: 60 years of errors and advances. Br J Dermatol. 2015;173(5):1250-1254. doi:10.1111/bjd.13989
4.
WhiteKDAbeRArdern-JonesMet al. SJS/TEN 2017: building multidisciplinary networks to drive science and translation. J Allergy Clin Immunol Pract. 2018;6(1):38-69. doi:10.1016/j.jaip.2017.11.023
5.
ZimmermannSSekulaPVenhoffMet al. Systemic immunomodulating therapies for Steven-Johnson syndrome and toxic epidermal necrolysis: a systematic review and meta-analysis. JAMA Dermatol. 2017;153(6):514-522. doi:10.1001/jamadermatol.2016.5668
PoizeauFGaudinOLe CleachLet al. Cyclosporine for epidermal necrolysis: absence of beneficial effect in a retrospective cohort of 174 patients-exposed/unexposed and propensity score-matched analyses. J Invest Dermatol. 2018;138(6):1293-1300. doi:10.1016/j.jid.2017.12.034
8.
Bellodi-SchmidtFShahKN. Beyond psoriasis: novel uses for biologic response modifiers in pediatric dermatology. Pediatr Dermatol. 2016;33(1):18-27. doi:10.1111/pde.12707
9.
WangCWYangLYChenCBet al; the Taiwan Severe Cutaneous Adverse Reaction (TSCAR) Consortium. Randomized, controlled trial of TNF-α antagonist in CTL-mediated severe cutaneous adverse reactions. J Clin Invest. 2018;128(3):985-996. doi:10.1172/JCI93349
10.
GaviganGMKanigsbergNDRamienML. Pediatric Stevens-Johnson syndrome/toxic epidermal necrolysis halted by etanercept. J Cutan Med Surg. 2018;22(5):514-515. doi:10.1177/1203475418758989
11.
ShearNHJaque-SilvaAMereniukAJeschkeMG. Sunnybrook protocol for treatment of toxic epidermal necrolysis. J Cutan Med Surg. 2018;22(5):535. doi:10.1177/1203475418770580
12.
ChungWHHungSIHongHSet al. Medical genetics: a marker for Stevens-Johnson syndrome. Nature. 2004;428(6982):486. doi:10.1038/428486a
